Clive Efford

The impact of a Hepatitis infection can range from very mild to very severe, including liver failure and death as a direct result of the infection. In its second interim report, the Infected Blood Inquiry recommended that the compensation scheme should reflect the different impacts of infection by developing severity bandings.

The Expert Group provided the Government with clinical advice on the distinctions between these impacts. This meant the Government could set severity bands for Hepatitis infections based on clear clinical markers.

As set out in the Infected Blood Compensation Scheme Regulations 2025, where someone’s experience of Hepatitis, whether it is historic or in the present day, has been more severe, they will receive more compensation.

As I said in my oral evidence to the Inquiry, I am open to considering a number of areas of the Scheme where doing so does not cause undue delay to the delivery of compensation. The Inquiry will be producing a further report and the Government will respond to this report when it is published.

As I said in my oral evidence to the Inquiry, I am open to considering a number of areas of the Scheme where doing so does not cause undue delay to the delivery of compensation. The Inquiry will be producing a further report and the Government will respond to this report when it is published

The Infected Blood Inquiry Response Expert Group provided advice on the design of infection severity bands for the core route. They considered the health impacts and treatments that applicants are likely to have experienced. This includes many side effects of treatments, including interferon, and conditions such as chronic fatigue. The core route tariffs therefore already take into account conditions that infected people are likely to experience as a result of their infection or treatment.

The supplementary route, as set out in the Infected Blood Compensation Scheme Regulations 2025, provides additional awards for applicants whose circumstances necessitate a higher compensation payment. As a result, the eligibility criteria for the Severe Health Condition award reflects the conditions and impacts the Expert Group identified as not being addressed in other aspects of the scheme, including the core route or Exceptional Loss award.

The Government has clearly laid out its priorities in the manifesto and in the King’s speech, and the second part of Leveson is not among them. There are no current plans for further legislation.

Utility companies are already incentivised to complete works on time with charges of up to £10,000 per day for works that overrun. We have announced that these charges will apply to weekends and bank holidays. We are also doubling fixed penalty notices for companies that breach permit conditions. These conditions can include setting days and times when works can take place.

Utility companies are already incentivised to complete works on time with charges of up to £10,000 per day for works that overrun. We have announced that these charges will apply to weekends and bank holidays. We are also doubling fixed penalty notices for companies that breach permit conditions. These conditions can include setting days and times when works can take place.

The Department has asked NHS England to continue to progress work on the Infusions and Special Medicines Programme, which is tasked with the implementation of Lord Carter’ 2020 report, Transforming Pharmacy Aseptic Services in England. The work included publication of guidance for the quality assurance of aseptic production in National Health Service hospitals and improved audits in unlicensed aseptic medicines preparation units, using digital tools to improve the transparency of the work. These hospital aseptic medicines preparation units make unlicensed ‘special’ medicines, which include ready to administer chemotherapy injections and intravenous nutrition products. The majority of these units are regulated by the Care Quality Commission.

A minority of aseptic medicines preparation services in hospitals are licensed units with a Medicines and Healthcare products Regulatory Agency (MHRA) Specials Authorisation. These units are regulated by the MHRA.

The Department has asked NHS England to continue to progress work on the Infusions and Special Medicines Programme, which is tasked with the implementation of Lord Carter’ 2020 report, Transforming Pharmacy Aseptic Services in England. The work included publication of guidance for the quality assurance of aseptic production in National Health Service hospitals and improved audits in unlicensed aseptic medicines preparation units, using digital tools to improve the transparency of the work. These hospital aseptic medicines preparation units make unlicensed ‘special’ medicines, which include ready to administer chemotherapy injections and intravenous nutrition products. The majority of these units are regulated by the Care Quality Commission.

A minority of aseptic medicines preparation services in hospitals are licensed units with a Medicines and Healthcare products Regulatory Agency (MHRA) Specials Authorisation. These units are regulated by the MHRA.

British passports meet the standards set by the International Civil Aviation Organisation (ICAO). While these standards permit the use of either diacritic marks or their transliteration, the number of countries that have adopted use of diacritics in their passport is very low.

There are currently no plans to introduce the inclusion of diacritic marks in the British passport. However, this will remain a consideration ahead of any future system developments.